Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Acurx Pharmaceuticals Inc
(NQ:
ACXP
)
2.430
-0.050 (-2.02%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Acurx Pharmaceuticals Inc
< Previous
1
2
Next >
Acurx Pharmaceuticals Leverages IPO Capital To Develop Most Significant Advance To Antibiotics In More Than 40 Years (NASDAQ: ACXP)
July 28, 2021
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Securities Market
Acurx Pharmaceuticals On Pace To Deliver The Most Important Upgrade To Antibiotics Since The 1980s (NASDAQ: ACXP)
July 15, 2021
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Securities Market
Post-IPO Acurx Pharmaceuticals Expects To Deliver The First Meaningful Change To Antibiotics Market Since 1980s (NASDAQ: ACXP)
July 08, 2021
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Securities Market
Acurx Pharmaceuticals Shares 15% Higher Post-IPO; On Track To Bring A New Class Of Effective Antibiotics To Market (NASDAQ: ACXP)
June 30, 2021
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Securities Market
Acurx Pharmaceuticals Shares Surge 31% Following Its Debut Public Offering; Low Share Count And $15 Million Presents A Compelling Investment Opportunity
June 28, 2021
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Securities Market
Acurx Pharmaceuticals Draws Interest After Morning IPO; Could Deliver First Class Of New Antibiotics Since The 1980’s (Nasdaq: ACXP)
June 25, 2021
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Securities Market
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.